ImmuView COVID-19 Antigen Home Test R0182CHT

GUDID 00855402007955

The lmmuView® COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. The lmmuView® COVID-19 Antigen Home Test does not differentiate between SARS-CoV and SARS-CoV-2. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen, which is generally detectable in anterior nasal (nares) swab specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Individuals who test positive with the lmmuView® COVID-19 Antigen Home Test should self-isolate and seek follow-up care with their physician or healthcare provider as additional testing may be necessary. All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks. Negative results should be

CTK BIOTECH INC.

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

• Primary Device ID: 00855402007955
• NIH Device Record Key: e1a99d6a-0deb-4313-9c84-bf16649202e8
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: ImmuView COVID-19 Antigen Home Test
• Version Model Number: R0182CHT-2T
• Catalog Number: R0182CHT
• Company DUNS: 081099976
• Company Name: CTK BIOTECH INC.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: true
• Manufacturing Date: true
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: true

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 30 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	00855402007955 [Primary]

FDA Product Code

• QKP: Coronavirus Antigen Detection Test System.

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2023-06-16
• Device Publish Date: 2023-06-08

On-Brand Devices [ImmuView COVID-19 Antigen Home Test]

• 00855402007979: The lmmuView® COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the
• 00855402007962: The lmmuView® COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the
• 00855402007955: The lmmuView® COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the